These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16120423)

  • 21. Wolff-Parkinson-White syndrome in Patients With MELAS.
    Sproule DM; Kaufmann P; Engelstad K; Starc TJ; Hordof AJ; De Vivo DC
    Arch Neurol; 2007 Nov; 64(11):1625-7. PubMed ID: 17998445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evolution until death of two members of a family with A3243G mutation and MELAS phenotype versus diabetes mellitus].
    Pérez López-Fraile MI; Barrena R; Montoya J; Marta E
    Neurologia; 2006; 21(6):327-32. PubMed ID: 16799910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MELAS and L-arginine therapy.
    Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Katayama K; Matsuishi T
    Mitochondrion; 2007; 7(1-2):133-9. PubMed ID: 17276739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial dysfunction in MELAS improved by l-arginine supplementation.
    Koga Y; Akita Y; Junko N; Yatsuga S; Povalko N; Fukiyama R; Ishii M; Matsuishi T
    Neurology; 2006 Jun; 66(11):1766-9. PubMed ID: 16769961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute blindness.
    Abboud H; Sabbagh C
    Emerg Med J; 2008 Nov; 25(11):779-80. PubMed ID: 18955627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated thyroid peroxidase antibodies with encephalopathy in MELAS syndrome.
    Chan DW; Lim CC; Tay SK; Choong CT; Phuah HK
    Pediatr Neurol; 2007 Jun; 36(6):414-7. PubMed ID: 17560506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive decline as a manifestation of mitochondrial disorders (mitochondrial dementia).
    Finsterer J
    J Neurol Sci; 2008 Sep; 272(1-2):20-33. PubMed ID: 18572195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2.
    Sasarman F; Antonicka H; Shoubridge EA
    Hum Mol Genet; 2008 Dec; 17(23):3697-707. PubMed ID: 18753147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation.
    Finsterer J
    Acta Neurol Scand; 2007 Jul; 116(1):1-14. PubMed ID: 17587249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of oxidative stress around the stroke-like lesions of MELAS patients.
    Katayama Y; Maeda K; Iizuka T; Hayashi M; Hashizume Y; Sanada M; Kawai H; Kashiwagi A
    Mitochondrion; 2009 Sep; 9(5):306-13. PubMed ID: 19393775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders.
    Rodriguez MC; MacDonald JR; Mahoney DJ; Parise G; Beal MF; Tarnopolsky MA
    Muscle Nerve; 2007 Feb; 35(2):235-42. PubMed ID: 17080429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Infantile encephalopathy associated with the MELAS A3243G mutation. Case report].
    Guevara-Campos J; Gonzalez-Guevara L; Parada Y; Urbáez-Cano J
    Invest Clin; 2007 Jun; 48(2):243-8. PubMed ID: 17598646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Headache and mitochondrial disorders.
    Rosen N
    Headache; 2008 May; 48(5):733-4. PubMed ID: 18471127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of complex I genes in MELAS: a novel heteroplasmic mutation 3380G>A in ND1 of mtDNA.
    Horváth R; Reilmann R; Holinski-Feder E; Ringelstein EB; Klopstock T
    Neuromuscul Disord; 2008 Jul; 18(7):553-6. PubMed ID: 18590963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anesthetic management of an obstetric patient with MELAS syndrome: case report and literature review.
    Maurtua M; Torres A; Ibarra V; DeBoer G; Dolak J
    Int J Obstet Anesth; 2008 Oct; 17(4):370-3. PubMed ID: 18691868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-gene stroke disorders.
    Majersik JJ; Skalabrin EJ
    Semin Neurol; 2006 Feb; 26(1):33-48. PubMed ID: 16479442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of known base substitution mutations in human mitochondrial DNA of MERRF and MELAS by biochip technology.
    Du W; Li W; Chen G; Cao H; Tang H; Tang X; Jin Q; Sun Z; Zhao H; Zhou W; He S; Lv Y; Zhao J; Zhang X
    Biosens Bioelectron; 2009 Apr; 24(8):2371-6. PubMed ID: 19155171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Big strokes in small persons.
    Adams RJ
    Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuropsychologic deficits of MELAS: evidence of global impairment.
    Neargarder SA; Murtagh MP; Wong B; Hill EK
    Cogn Behav Neurol; 2007 Jun; 20(2):83-92. PubMed ID: 17558251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging advances and the transformation of acute stroke care.
    Kim D; Liebeskind DS
    Semin Neurol; 2005 Dec; 25(4):345-61. PubMed ID: 16341991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.